A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the tolerability and effectiveness of
atomoxetine in the treatment of attention problems, hyperactivity, and impulsivity in
children with ASD, and secondarily, to evaluate the possible response to atomoxetine on the
core symptoms of ASD